
Jeil Pharma Holdings Inc
Symbol: 002620.KS
KSC
13770
KRWcompany-market-status
-3.5834
P/E ratio
0.0169
PEG ratio
211.38B
Mrk Cap
- 0.00%
Div Yield
- Highest
- 28600.00
- 24600.00
- 31150.00
- 21000.00
- 26350.00
- 24200.00
- 23100.00
- 20400.00
- 15500.00
- 18350.00
- 10300.00
- 19550.00
- 19100.00
- 27150.00
- 26000.00
- 20900.00
- 18150.00
- 25100.00
- 25700.00
- 20500.00
- 18400.00
- 17350.00
- 15250.00
- 13300.00
- 14100.00
- 12100.00
- 13450.00
- 12600.00
- 9700.00
- 10350.00
- 13820.00
- Lowest
- 28150.00
- 23950.00
- 30100.00
- 19450.00
- 25550.00
- 23650.00
- 21700.00
- 17300.00
- 15150.00
- 17800.00
- 9250.00
- 19000.00
- 18600.00
- 25800.00
- 25200.00
- 18900.00
- 17800.00
- 24350.00
- 25350.00
- 19600.00
- 17600.00
- 17000.00
- 14450.00
- 12750.00
- 13700.00
- 11100.00
- 13100.00
- 12200.00
- 9410.00
- 10150.00
- 13030.00
Информация за компанията
Jeil Pharma Holdings Inc manufactures and sells ingredients of drugs, incrementally modified drugs, and generic drugs in South Korea. The company offers active pharmaceutical ingredients in the areas of antibiotics, gastrointestinal, cardiovascular, neuropsychiatry, oncology, endocrinology, urology, antiviral, and antihistamines, as well as patch products. It also provides finished dosage forms in the areas of anti-bacteria and anti-fungal, anti-virus, cardiovascular, endocrinology, neurology, gastrointestinal, urology, oncology, anti-histamine, rheumatology, respiratory, otolaryngological, heaptic, laxatives, and purgatives. The company exports its products to approximately 40 countries in the Association of Southeast Asian Nations, Central and South America, Africa, etc. Jeil Pharma Holdings Inc was founded in 1959 and is headquartered in Seoul, South Korea.
Оборотен капитал
2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
---|---|---|---|---|---|---|
Парични средства и инвестиции | 34759.51 | 28580.78 | 20183.39 | 21236.95 | 41098.11 | 8753.84 |
Приемници | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Инвентарна книга | 113265.72 | 114242.90 | 124150.48 | 96784.32 | 97562.76 | 6255.33 |
Други | 4943.53 | 5728.18 | 0.00 | 4633.19 | 195581.84 | 18671.54 |
Общо текущи активи | 352916.44 | 335143.72 | 335074.17 | 313620.34 | 337927.94 | 38523.42 |
Acc Payable | 162967.42 | 159388.34 | 149264.53 | 157545.16 | 151126.76 | 5000.18 |
Краткосрочен дълг | 119087.35 | 94964.49 | 137208.89 | 108492.88 | 95171.54 | 678.58 |
Други текущи пасиви | 76449.98 | 43670.72 | 40844.03 | 47790.84 | 32833.65 | 8780.23 |
Текущи пасиви | 358504.74 | 298023.55 | 327317.45 | 313828.87 | 280976.70 | 15367.63 |
Общо активи
254455,73 щ.д.
Общо задължения
114689249000,00 щ.д.
Дългосрочен дълг
60,00 щ.д.
Парични средства и екви
9849386000,00 щ.д.
Goodwill
0,00 щ.д.
Неразпределена печалба
111670309000,00 щ.д.
Обикновени акции
7986,68 щ.д.
Стойност на предприятието
-2,24 щ.д.
Години | Q1 | Q2 | Q3 | Q4 | Общо |
---|---|---|---|---|---|
2000 | 66.663 | 0.000 | 0.000 | 0.000 | 66.663 |
2001 | 170.866 | 0.000 | 0.000 | 239.212 | 410.078 |
2002 | 0.000 | 0.000 | 0.000 | 341.732 | 341.732 |
2003 | 0.000 | 0.000 | 0.000 | 341.732 | 341.732 |
2004 | 0.000 | 0.000 | 0.000 | 375.905 | 375.905 |
2005 | 0.000 | 0.000 | 0.000 | 392.992 | 392.992 |
2006 | 0.000 | 0.000 | 0.000 | 341.732 | 341.732 |
2007 | 0.000 | 0.000 | 0.000 | 358.819 | 358.819 |
2008 | 0.000 | 0.000 | 0.000 | 205.039 | 205.039 |
2009 | 0.000 | 0.000 | 0.000 | 341.732 | 341.732 |
2010 | 0.000 | 0.000 | 0.000 | 341.732 | 341.732 |
2011 | 0.000 | 0.000 | 0.000 | 307.559 | 307.559 |
2012 | 0.000 | 0.000 | 0.000 | 205.039 | 205.039 |
2013 | 0.000 | 0.000 | 0.000 | 136.693 | 136.693 |
2014 | 0.000 | 0.000 | 0.000 | 205.039 | 205.039 |
2015 | 0.000 | 0.000 | 0.000 | 205.039 | 205.039 |
2016 | 0.000 | 0.000 | 0.000 | 239.212 | 239.212 |
2017 | 0.000 | 0.000 | 0.000 | 60.000 | 60.000 |
2018 | 0.000 | 0.000 | 0.000 | 70.000 | 70.000 |
2019 | 0.000 | 0.000 | 0.000 | 70.000 | 70.000 |
2020 | 0.000 | 0.000 | 0.000 | 70.000 | 70.000 |
2021 | 0.000 | 0.000 | 0.000 | 65.000 | 65.000 |
2022 | 0.000 | 0.000 | 0.000 | 50.000 | 50.000 |